CEP-32215 is a new, potent and selective H3R inverse agonist.
Human H3R Ki = 2.0 with potent functional and inverse agonist activity (EC50 = 0.6 nM).
Functional antagonism in the rat dipsogenia model (ED50 = 0.92 mg/kg p.o.).
Active in the rat EEG model from 3 to 30 mg/kg p.o. with no undesirable events.